StockData
Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc. (VERA) stock

VERANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$26.20−0.77 (-2.86%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Vera Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Vera Therapeutics's market cap was $2.08B on Nov 11, 2026, against $2.13B a year earlier. Over the last 5 years it ranged from $161.74M to $3.19B, with a median of $1.38B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.08B-34.8%
2025Dec 31, 2025$3.19B+47.2%
2024Dec 31, 2024$2.17B+266.1%
2023Dec 29, 2023$592.24M+22.6%
2022Dec 30, 2022$483.19M+122.8%
2021Dec 31, 2021$216.85M–

More Vera Therapeutics figures

See a number that looks wrong?